Seminars & Events

Neurosciences Gateway

The University of Utah’s top-rated physicians and researchers are at the forefront of neuroscience: pioneering treatments in health care, breaking ground in imaging techniques, designing new solutions for brain and spinal cord repair, and more. The Neurosciences Gateway is a portal to discovering more about the U of U’s neuroscience expertise, distributed among many departments, centers, and institutes.

Launched in Fall, 2014, the Neuroscience Initiative unites the academic, translational, and clinical neuroscience communities toward the common goals of better understanding the brain in disease and in health. Learn more.


Upcoming Neuroscience Initiative Events:

Mood & Behavior Disorders Symposium (April 29, 2015, 9:00 AM-2:45 PM): Branch Auditorium, University Neuropsychiatric Institute, 501 Chipeta Way, Salt Lake City UT.  Note on parking:  Parking is free, but there is no parking in the west lot at the front of the building. Please park in the east lot behind the building.

To RSVP, please fill out this form no later than April 24. Email with any questions. 

Program Summary:

9:00-9:30 Continental Breakfast & Opening Remarks
9:30-12:00 Morning Sessions: Autism & Addiction
12:00-1:30 Lunch & Research Vignettes
1:30-2:30 Afternoon Session: Mood Disorders
2:30-2:45 Closing Remarks

 Please click here for the complete program.

Presentation by Dr. Matthew Anderson, MD, PhD, Harvard Medical School (May 14, 2015; 12:30-1:30 PM):Nucleating a Feisty Autism Gene Network. Health Sciences Education Building Room 1750.

Demyelinating & Neuroinflammatory Diseases Symposium (June 11, 2015, 8:00 AM-4:15 PM): Health Sciences Education Building Alumni Hall, Salt Lake City UT. Currently soliciting research abstracts, please email if you are interested in sharing your work. To RSVP, please fill out this form.

Program Summary:

8:00-8:30 Continental Breakfast & Opening Remarks
8:30-11:40 Session 1: Neuroinflammation & Glial Biology
11:45-1:00: Lunch & Poster Viewing
1:00-3:30 Session 2: Pathology of Disease
3:30-4:00 New Frontiers in Human Immunotherapy & Closing Remarks


Allen Brain Institute Workshop @ Snowbird (October 31, 2015):Stay tuned for details!

Neuroscience Community Events:

Keck Foundation Information Session (May 11, 2015): Recommended for faculty planning to submit a concept paper to the Keck Foundation. A. Ray Olpin Union Den, 3:00-4:00 PM. See the invitation here.

IMFAR Pre-conference (May 13, 2015): Email for more information. Little America Hotel, Salt Lake City UT. Please note that while the meeting is full, you can still register for FREE streaming access to the pre-conference.

ADD Program Symposium (May 17-19, 2015):Therapy Development in the Era of Team Science & Big Data: What Will the Future Bring to the Patient with Epilepsy? Park City Marriot, Park City UT.

Funding Opportunities:

The Brain Mind Institute - Kaloy Prize 2015: The Ecole Polytechnique Federale de Lausanne and the Kaloy Foundation have created this $10,000 prize to link neuroscience research to philosophical questions. The Prize is awarded for work in neuroscience, biology, physics, or psychology which confirms, refutes, or elucidates a theory of the philosophy of mind or epistemology. Applications are due April 30. Download this flyer for details.

W.M. Keck Foundation Call for Concept Papers: The Health Sciences Development Office is seeking one-page concept papers for transformative, "edgy" projects in science, engineering, or medical research. Download the email from UUHS Prospect Management here, or visit for more details. Internal applications are due May 22.

Extended Deadline for the Brain Research Foundation: The University of Utah has extended the internal submission deadline for applications to the Brain Research Foundation's Annual Scientific Innovations Award to May 15. Find out more on CompetitionSpace.

CCTS & Program in Personalized Health Pilot Project grants: The University of Utah's Center for Clinical and Translational Science and the Program in Personalized Health announce a request for proposals for pilot projects describing innovative approaches to personalized health and/or translational research. Grant proposals are due May 29, 2015. Please see CompetitionSpace for more information and to submit.

HHMI, Gates Foundation, & Simons Foundation 2016 Faculty Scholars Competition: A national competition for outstanding scientists. Find the program announcement here.

NIH Blueprint wants your input on neuroscience funding priorities: Visit to provide your ideas for how NIH Blueprint might best invest its future funds.


U Researchers Develop Neural Implant So Amputees Can Move – and Feel – Prosthetic Hand

University of Utah researchers have received $1.4 million to further develop an implantable neural interface that will allow an amputee to move an advanced prosthetic hand with just his or her thoughts. The neural interface will also convey feelings of touch and movement.

Called the Utah Slanted Electrode Array, the neural interface uses 100 electrodes that connect with nerves in an amputee’s arm to read signals from the brain telling the hand how to move. Likewise, the neural interface delivers meaningful sensations of touch and movement from a prosthetic hand back to the brain. READ MORE

Listen to an interview about the research on The Scope Radio.

New Insights Into Causes of ALS

University of Utah neurologists Summer Gibson, M.D., and Stefan Pulst, M.D., are authors on a collaborative, multi-institutional study published in the journal Science. The research identifies mutations in a gene, TBK1, as contributing to ALS. Taken together with previous findings, the discovery highlights defects in biological pathways – autophagy and inflammation - as potential key players in development of the disease.

"This is particularly important because TBK1 is involved in the same natural immunity and autophagy pathways as two other previously identified ALS genes, optineurin (OPTN) and p62 (SQSTM1/sequestosome)," says Gibson. Autophagy in particular may be important for destruction of prion-like structures that accumulate in the brains of some patients. The findings suggest a novel course of therapeutic interventions for treating the disease.